Chemotherapy News and Research

Latest Chemotherapy News and Research

Study shows skin rash in patients treated for liver cancer determines survival

In a study of a new chemotherapy drug for liver cancer, researchers found that the development of a skin rash correlated directly with the patient's response to treatment.

6 Jun 2006

Addition of gemcitabine to standard postoperative treatment increased pancreatic cancer patients' survival by 50 percent

Adding the cancer-fighting drug gemcitabine to standard therapy after surgery significantly improves survival for patients with the most common form of pancreatic cancer, according to a new multicenter study led by a University of Maryland radiation oncologist.

6 Jun 2006

Advanced prostate cancer can be treated successfully with intermittent chemotherapy

Advanced prostate cancer can be treated successfully with intermittent chemotherapy, according to a study conducted by Oregon Health & Science University Cancer Institute scientists.

6 Jun 2006

Sunitinib malate shows promise against advanced form of lung cancer

Results of a multi-center clinical study of a drug currently approved for treatment of kidney cancer indicate that it may also be effective for people with recurrent and advanced lung cancer.

5 Jun 2006

Sunitinib malate drug shows significant benefits over standard treatment for advanced kidney cancer

According to a new study, the drug sunitinib malate (Sutent.) is more effective than the current standard cytokine treatment given as an initial therapy for patients with advanced kidney cancer, also known as metastatic renal cell carcinoma (mRCC).

5 Jun 2006

Taxotere combined with standard chemotherapy improves survival in advanced head and neck cancers

The addition of docetaxel (Taxotere) to an initial chemotherapy regimen for inoperable head and neck cancers reduced mortality by nearly 30 percent over three years following treatment compared to the standard two-drug combination.

5 Jun 2006

HERA trial continues to demonstrate significant patient benefits from Herceptin

New 23-month follow-up data from HERA, one of the largest breast cancer trials ever carried out, show that Herceptin (trastuzumab) following standard chemotherapy significantly reduced the risk of death by 34% for women with early-stage HER2-positive breast cancer.

5 Jun 2006

Genes variations raise risk of heart disease after treatment for childhood cancer

Gene variations may raise the risk that survivors of childhood cancer will suffer congestive heart failure as a complication of drugs they received during cancer treatment.

5 Jun 2006

"Smart bomb" cancer therapy combo effective

Experts have more good news on the breast cancer front; they say they by using a combination of therapies it may be possible to extend the lives of thousands of women with advanced breast cancer.

4 Jun 2006

Scientists use "small interfering RNAs" to block the spread of human colorectal cancer cells

Using one of the newest and most powerful tools of biomedical science, University of Texas Medical Branch at Galveston (UTMB) researchers have scored a dramatic success in the battle against colorectal cancer.

1 Jun 2006

Molecular diagnostic test for early-stage breast cancer

Researchers at Montefiore Medical Center are leading a nationwide clinical trial to determine whether a new genetic test can be used to personalize treatment for early-stage breast cancer.

1 Jun 2006

Experimental treatment increases response rates in advanced lung cancer

An early phase study pairing an experimental targeted therapy with a common anti-inflammatory produced promising results in patients with advanced lung cancer, researchers at UCLA's Jonsson Cancer Center reported.

1 Jun 2006

EU ruling on breast drug Herceptin will end 'post code lottery' in Britain

The European Union has approved the use of the breast cancer drug Herceptin for use in patients with an early stage of the aggressive HER2-positive type of breast cancer.

24 May 2006

Role of partial nephrectomy in the treatment of upper tract transitional cell carcinoma

Traditionally, upper tract transitional cell carcinoma (TCC) is managed with nephroureterectomy with excision of a bladder cuff.

22 May 2006

OK from the FDA for synthetic marijuana drug

Despite saying quite recently that it does not support the use of marijuana for medical purposes, the U.S. Food and Drug Administration (FDA) has given marketing approval for a drug which is a synthetic version of the active ingredient in marijuana.

17 May 2006

First animal model that mimics human head and neck cancer

An Oregon Health & Science University Cancer Institute research laboratory has developed a novel mouse model designed specifically to study the often devastating head and neck squamous cell cancers.

16 May 2006

Gene amplification could guide treatment for high-risk breast cancer

A new study shows that breast cancer patients with an "amplification," or greater number of copies, of the TOP2A gene are 45% more likely than women who do not have this amplification to benefit from a longer course of anthracycline-based adjuvant chemotherapy.

11 May 2006

Chemotherapy News and Research

Latest Chemotherapy News and Research

Study shows skin rash in patients treated for liver cancer determines survival

Addition of gemcitabine to standard postoperative treatment increased pancreatic cancer patients' survival by 50 percent

Advanced prostate cancer can be treated successfully with intermittent chemotherapy

Sunitinib malate shows promise against advanced form of lung cancer

Sunitinib malate drug shows significant benefits over standard treatment for advanced kidney cancer

Taxotere combined with standard chemotherapy improves survival in advanced head and neck cancers

HERA trial continues to demonstrate significant patient benefits from Herceptin

Genes variations raise risk of heart disease after treatment for childhood cancer

"Smart bomb" cancer therapy combo effective

Scientists use "small interfering RNAs" to block the spread of human colorectal cancer cells

Molecular diagnostic test for early-stage breast cancer

Experimental treatment increases response rates in advanced lung cancer

EU ruling on breast drug Herceptin will end 'post code lottery' in Britain

Role of partial nephrectomy in the treatment of upper tract transitional cell carcinoma

OK from the FDA for synthetic marijuana drug

First animal model that mimics human head and neck cancer

Gene amplification could guide treatment for high-risk breast cancer

Promising chemo, therapeutic viruses, cutting-edge surgery debut at M. D. Anderson Cancer Center

Online infusion calculator and a computerized drug ordering system reduces medication errors in children

Significant changes in tumor growth can be detected through short interval follow-up

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in